Trial Profile
Efficacy, Dose-ranging and Safety Evaluation (A Randomized, Double- or Evaluator-blinded, Active- and Placebo-controlled, Single Dose, Five-arm, Crossover, and Dose-ranging Study of A006 in Adult Asthma Patients)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Apr 2017
Price :
$35
*
At a glance
- Drugs Salbutamol (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Acronyms A006-B3
- Sponsors Amphastar Pharmaceuticals
- 21 Oct 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 11 Aug 2014 New trial record